Thanks to our friends at GeekWire for catching that Portland biotech startup Araceli Biosciences has landed $11.2 million to fund their ongoing development of their AI enhanced imagining technology designed to speed drug discovery.
“The future of AI-driven drug discovery and personalized medicine depends on imaging and analysis that happens in real time,” Matt Beaudet, CEO of Araceli Biosciences, said in a news release. “Minutes and seconds matter. The old model of waiting hours — or even days — for data is over. At Araceli, we’re building a platform that moves at the speed of science.”
For more information, read “Araceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discovery.”
More Portland startup news
